Armata Pharmaceuticals (ARMP) EBT Margin (2013 - 2020)
Armata Pharmaceuticals (ARMP) posted EBT Margin of 17712.9% for Q2 2020, down 172.98% sequentially from 24270.0% in Q4 2017.
Armata Pharmaceuticals (ARMP) EBT Margin (2013 - 2020) Analysis & Trends
Armata Pharmaceuticals has reported EBT Margin for 6 years, with the latest figure at 17712.9% in Q2 2020.
- Quarterly EBT Margin changed N/A year-over-year to 17712.9% in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 3221.37% (changed N/A YoY) and the FY2017 annual result came in at 6029.57%, down 358418.0% from the prior year.
- EBT Margin fell to 17712.9% in Q2 2020 per ARMP's latest filing, from 24270.0% in the prior quarter.
- Over five years, EBT Margin peaked at 24270.0% in Q4 2017 and troughed at 27725.0% in Q2 2017.
- A 3-year average of 4187.36% and a median of 4478.37% in 2016 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2016 and 2017: EBT Margin soared 1584233 bps in 2016, then sank 2398617 bps in 2017.
- Over 3 years, EBT Margin stood at 13545.45% in 2016, then soared by 79 bps to 24270.0% in 2017, then tumbled by 173 bps to 17712.9% in 2020.
- According to Business Quant data, EBT Margin over the past three periods registered 17712.9%, 24270.0%, and 2050.0% for Q2 2020, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -17,712.90% |
| Dec 31, 2017 | 24,270.00% |
| Sep 30, 2017 | -2,050.00% |
| Jun 30, 2017 | -27,725.00% |
| Mar 31, 2017 | -11,606.90% |
| Dec 31, 2016 | 13,545.45% |
| Sep 30, 2016 | -8,189.66% |
| Jun 30, 2016 | -3,738.83% |
| Mar 31, 2016 | -4,478.37% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,877.51% |
| Jun 30, 2015 | -3,022.63% |
| Mar 31, 2015 | -4,733.33% |
| Dec 31, 2014 | 6,114.85% |
| Sep 30, 2014 | -5,916.49% |
| Jun 30, 2014 | -10,089.80% |
| Mar 31, 2014 | -10,872.12% |
| Dec 31, 2013 | 1,026.19% |
| Sep 30, 2013 | -78,333.33% |
| Jun 30, 2013 | -1,991.08% |